BANK OF AMERICA CORP /DE/ - CHELSEA THERAPEUTICS INTL LT ownership

CHELSEA THERAPEUTICS INTL LT's ticker is CHTP and the CUSIP is 163428105. A total of 60 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q2 2013. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CHELSEA THERAPEUTICS INTL LT
ValueSharesWeighting
Q1 2014$278,000
+1108.7%
50,249
+866.3%
0.00%
Q4 2013$23,000
-82.0%
5,200
-87.9%
0.00%
Q3 2013$128,000
-65.1%
42,886
-73.1%
0.00%
Q2 2013$367,000159,3790.00%
Other shareholders
CHELSEA THERAPEUTICS INTL LT shareholders Q2 2013
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 100,000$13,400,0000.04%
WHITEBOX ADVISORS LLC 2,777,092$555,0000.02%
CSS LLC/IL 45,000$290,0000.01%
Polar Asset Management Partners Inc. 750,000$60,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 396,300$2,584,0000.00%
NORTHERN TRUST CORP 648,574$4,229,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 56,400$368,0000.00%
AMERIPRISE FINANCIAL INC 30$00.00%
DEUTSCHE BANK AG\ 23$00.00%
CITIGROUP INC 74$00.00%
View complete list of CHELSEA THERAPEUTICS INTL LT shareholders